These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36788984)

  • 21. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
    Hornick JL; Dal Cin P; Fletcher CD
    Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.
    Sakharpe A; Lahat G; Gulamhusein T; Liu P; Bolshakov S; Nguyen T; Zhang P; Belousov R; Young E; Xie X; Rao P; Hornick JL; Lazar AJ; Pollock RE; Lev D
    Oncologist; 2011; 16(4):512-22. PubMed ID: 21357725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine and docetaxel for epithelioid sarcoma: results from a retrospective, multi-institutional analysis.
    Pink D; Richter S; Gerdes S; Andreou D; Tunn PU; Busemann C; Ehninger G; Reichardt P; Schuler MK
    Oncology; 2014; 87(2):95-103. PubMed ID: 25011671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Treatment with Pazopanib for Multiple Lung Metastases of Inguinal Epithelioid Sarcoma: A Case Report.
    Irimura S; Nishimoto K; Kikuta K; Nakayama R; Susa M; Horiuchi K; Nakamura M; Matsumoto M; Morioka H
    Case Rep Oncol; 2015; 8(3):378-84. PubMed ID: 26500539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
    Weiss AR; Chen YL; Scharschmidt TJ; Chi YY; Tian J; Black JO; Davis JL; Fanburg-Smith JC; Zambrano E; Anderson J; Arens R; Binitie O; Choy E; Davis JW; Hayes-Jordan A; Kao SC; Kayton ML; Kessel S; Lim R; Meyer WH; Million L; Okuno SH; Ostrenga A; Parisi MT; Pryma DA; Randall RL; Rosen MA; Schlapkohl M; Shulkin BL; Smith EA; Sorger JI; Terezakis S; Hawkins DS; Spunt SL; Wang D
    Lancet Oncol; 2020 Aug; 21(8):1110-1122. PubMed ID: 32702309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
    Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
    Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution.
    Baratti D; Pennacchioli E; Casali PG; Bertulli R; Lozza L; Olmi P; Collini P; Radaelli S; Fiore M; Gronchi A
    Ann Surg Oncol; 2007 Dec; 14(12):3542-51. PubMed ID: 17909905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends of lymph node sampling and metastasis in pediatric and young adult patients with clear cell, epithelioid, and synovial sarcomas.
    Weller JH; Westermann C; Patel P; Beckman RM; Pratilas CA; Morris CD; Rhee DS
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29455. PubMed ID: 35466567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of cytopathologic features of epithelioid sarcoma in a series of 7 uncommon cases with immunohistochemical results, including loss of INI1/SMARCB1 in two test cases.
    Rekhi B; Singh N
    Diagn Cytopathol; 2016 Jul; 44(7):636-42. PubMed ID: 27145123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group.
    Frezza AM; Sbaraglia M; Lo Vullo S; Baldi GG; Simeone N; Frenos F; Campanacci D; Stacchiotti S; Pasquali S; Callegaro D; Gambarotti M; Barisella M; Palomba A; Mariani L; Casali PG; Dei Tos AP; Gronchi A
    Eur J Surg Oncol; 2020 Jul; 46(7):1320-1326. PubMed ID: 32307188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series.
    Yoo KH; Kim HS; Lee SJ; Park SH; Kim SJ; Kim SH; La Choi Y; Shin KH; Cho YJ; Lee J; Rha SY
    BMC Cancer; 2015 Mar; 15():154. PubMed ID: 25885855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of epithelioid sarcoma].
    Xing YM; Pan ZY; Li YW; Sun HY; Jang ZS; Xie GR
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):872-4. PubMed ID: 22335957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of sequential chemotherapy in epithelioid sarcoma.
    Czarnecka AM; Chmiel P; Błoński P; Świtaj T; Rogala P; Falkowski S; Koseła-Paterczyk H; Teterycz P; Kopeć S; Morysiński T; Wągrodzki M; Rutkowski P
    J Chemother; 2024 Aug; ():1-12. PubMed ID: 39115147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma.
    Kaya AO; Büyükberber S; Ozkan M; Alkiş N; Sevinc A; Ozdemir NY; Alici S; Esbah O; Berk V; Camci C; Ulas A; Coskun U; Benekli M;
    Asian Pac J Cancer Prev; 2012; 13(2):463-7. PubMed ID: 22524807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neck Epithelioid Sarcoma at an Unusual Location Mimicking Lymph Node Metastases of Nasopharyngeal Carcinoma: A Case Report.
    El Ouardani S; Chibani H; Rezzoug F; Kharkhach A; Al Jarroudi O; Brahmi SA; Afqir S
    Cureus; 2024 Mar; 16(3):e56484. PubMed ID: 38638767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.
    Pender A; Davis EJ; Chauhan D; Messiou C; Al-Muderis O; Thway K; Fisher C; Zaidi S; Miah A; Judson I; van der Graaf W; Keedy VL; Benson C; Jones RL
    Med Oncol; 2018 Aug; 35(10):131. PubMed ID: 30128716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Extremely Rare Epithelioid Sarcoma Arising from the Infratemporal Fossa: A Case Report and Literature Review.
    Ran W; Tang W; Duan J; Qing J; Zhai Z
    Curr Med Imaging; 2021; 17(6):798-806. PubMed ID: 33397242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis.
    Takahashi M; Komine K; Imai H; Okada Y; Saijo K; Takahashi M; Shirota H; Ohori H; Takahashi S; Chiba N; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(5):e0176972. PubMed ID: 28489919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
    Gounder MM; Merriam P; Ratan R; Patel SR; Chugh R; Villalobos VM; Thornton M; Van Tine BA; Abdelhamid AH; Whalen J; Yang J; Rajarethinam A; Duh MS; Bobbili PJ; Huynh L; Totev TI; Lax AK; Agarwal S; Demetri GD
    Cancer; 2021 Apr; 127(8):1311-1317. PubMed ID: 33296083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
    Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
    BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.